MFDS — authorised 18 October 2013
- Marketing authorisation holder: ACTELION PHARMS LTD
- Status: likely_approved
🇰🇷 Opsumit in South Korea
MFDS authorised Opsumit on 18 October 2013
Marketing authorisation
Opsumit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Opsumit approved in South Korea?
Yes. MFDS authorised it on 18 October 2013.
Who is the marketing authorisation holder for Opsumit in South Korea?
ACTELION PHARMS LTD holds the South Korean marketing authorisation.